Search

Your search keyword '"Pharmaceutically active compounds (PhACs)"' showing total 50 results

Search Constraints

Start Over You searched for: Descriptor "Pharmaceutically active compounds (PhACs)" Remove constraint Descriptor: "Pharmaceutically active compounds (PhACs)"
50 results on '"Pharmaceutically active compounds (PhACs)"'

Search Results

1. Evaluating Nanofiltration and Reverse Osmosis Membranes for Pharmaceutically Active Compounds Removal: A Solution Diffusion Model Approach

4. Pharmaceuticals and Personal Care Products in the Environment with Emphasis on Horizontal Transfer of Antibiotic Resistance Genes.

5. Environmental Risk Assessment of Pharmaceuticals in Wastewater Treatment

7. From monitoring to treatment, how to improve water quality: The pharmaceuticals case

8. Application of the model of cylindrical reactor for self-purification by indigenous microorganisms

9. Simultaneous determination of pharmaceuticals and metabolites in fish tissue by QuEChERS extraction and UHPLC Q/Orbitrap MS analysis.

10. Ultrasonically Facilitated Electrochemical Degradation of Acetaminophen Using Nanocomposite Porous Cathode and Pt Anode

12. Thermal baths as sources of pharmaceutical and illicit drug contamination.

13. Ultrasonically Facilitated Electrochemical Degradation of Acetaminophen Using Nanocomposite Porous Cathode and Pt Anode.

14. Risk assessment of pharmaceutically active compounds (PhACs) in the Klang River estuary, Malaysia.

15. Transformation of naproxen during the chlorination process: Products identification and quantum chemistry validation.

16. Diatom responses to sewage inputs and hydrological alteration in Mediterranean streams.

17. In tandem effects of activated carbon and quorum quenching on fouling control and simultaneous removal of pharmaceutical compounds in membrane bioreactors.

18. Environmental fate and ecotoxicological risk of the antibiotic sulfamethoxazole across the Katari catchment (Bolivian Altiplano): Application of the GREAT-ER model.

19. Decomposition of ibuprofen in water via an electrochemical process with nano-sized carbon black-coated carbon cloth as oxygen-permeable cathode integrated with ultrasound.

20. Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms.

21. Regional assessment of concentrations and sources of pharmaceutically active compounds, pesticides, nitrate, and E. coli in post-glacial aquifer environments (Canada).

22. Histological endpoints and oxidative stress transcriptional responses in the Mediterranean mussel Mytilus galloprovincialis exposed to realistic doses of salicylic acid

23. Screening determination of pharmaceutical pollutants in different water matrices using dual-channel capillary electrophoresis coupled with contactless conductivity detection.

24. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.

25. Construction of a stable porous composite with tunable graphene oxide in Ce-based-MOFs for enhanced solar-photocatalytic degradation of sulfamethoxazole in water.

26. In-situ chemical attenuation of pharmaceutically active compounds using CaO2: Influencing factors, mechanistic modeling, and cooperative inactivation of water-borne microbial pathogens.

27. Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine.

28. Histological endpoints and oxidative stress transcriptional responses in the Mediterranean mussel Mytilus galloprovincialis exposed to realistic doses of salicylic acid.

29. Removal of trace organic contaminants by an MBR comprising a mixed culture of bacteria and white-rot fungi.

30. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: An application to the Spanish case.

31. Impact of humic acid fouling on membrane performance and transport of pharmaceutically active compounds in forward osmosis.

32. Impact of chemical cleaning on the nanofiltration of pharmaceutically active compounds (PhACs): The role of cleaning temperature.

33. Changes in surface properties and separation efficiency of a nanofiltration membrane after repeated fouling and chemical cleaning cycles.

34. Effects of chemical cleaning on the nanofiltration of pharmaceutically active compounds (PhACs)

35. Systematic investigation of parameters affecting ozonation oxidation of emerging contaminants.

36. Effects of selected pharmaceutically active compounds on treatment performance in sequencing batch reactors mimicking wastewater treatment plants operations

37. Effects of selected pharmaceutically active compounds on the ammonia oxidizing bacterium Nitrosomonas europaea

38. Removal of sulfamethoxazole by nanofiltration membrane.

39. Freeze concentration for removal of pharmaceutically active compounds in water

40. Membrane adsorption of endocrine disrupting compounds and pharmaceutically active compounds

41. Liquid chromatography–tandem mass spectrometry of bioactive pharmaceutical compounds in the aquatic environment—a decade’s activities.

42. Environmental impact and biological removal processes of pharmaceutically active compounds: The particular case of sulfonamides, anticonvulsants and steroid estrogens

43. Environmental impact and biological removal processes of pharmaceutically active compounds: The particular case of sulfonamides, anticonvulsants and steroid estrogens.

44. Combined effects of urban pollution and hydrological stress on ecosystem functions of Mediterranean streams.

45. A review of the biotransformations of priority pharmaceuticals in biological wastewater treatment processes.

46. Attenuation of pharmaceutically active compounds in aqueous solution by UV/CaO2 process: Influencing factors, degradation mechanism and pathways.

47. [Distribution and Environmental Risk of Pharmaceutically Active Compounds in the Traditionally Aqueous Phase of Effluent-receiving Rivers].

48. Effects of organic and colloidal fouling on the rejection of two pharmaceutically active compounds (PhACs) by nanofiltration processes: role of membrane foulants.

49. Regional assessment of concentrations and sources of pharmaceutically active compounds, pesticides, nitrate, and E. coli in post-glacial aquifer environments (Canada)

Catalog

Books, media, physical & digital resources